Global registry for hip dysplasia in infants and children
Official title: A Prospective, Global Hip Dysplasia Registry with Follow-up to Skeletal Maturity: an Analysis of Risk Factors, Screening Practices and Treatment Outcomes
Run by University of British Columbia · NCT04117685 · Data updated 2026-11-12
This study is creating a global registry to track infants and children with hip dysplasia to see which treatments work best and improve care for this condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Minute to 10 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | September 1, 2016 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | November 18, 2024 |
| Trial ID | NCT04117685 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants and children aged 0 to 10 years who are diagnosed with DDH or referred for screening due to specific risk factors.
✕Probably not a fit
Patients over 10 years of age at the time of initial diagnosis or those with known neuromuscular or congenital anomalies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This initiative aims to create a comprehensive, prospective international registry for infants and children diagnosed with developmental dysplasia of the hip (DDH). By standardizing treatment and management strategies, the registry seeks to identify best practices and improve clinical outcomes for this common pediatric hip condition. The study will collect data on patients aged 0 to 10 years who are referred for DDH screening or diagnosed with the condition, confirmed through imaging. The goal is to address inconsistencies in diagnosis and treatment that currently exist due to variations in practices and terminology.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis, treatment, and management of hip dysplasia, ultimately enhancing outcomes for affected infants and children.
How similar studies have gone: While there have been numerous studies on DDH, this registry approach is novel and aims to unify data collection and treatment practices across different regions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 0 and 10 years at time of initial diagnosis * Referred for DDH screening due to specific risk factors OR diagnosed with DDH * Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging Exclusion Criteria: * Known or suspected neuromuscular, collagen, chromosomal or lower extremity congenital anomalies * Teratologic hip dislocation (syndromic-associated dislocations) * Over 10 years of age at initial diagnosis * Received prior treatment for DDH without appropriate imaging or documentation
Where it's running
-
British Columbia Children's Hospital
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Kishore Mulpuri, FRCSC — University of British Columbia
- Study coordinator: Emily K Schaeffer, PhD
- Email: emily.schaeffer@cw.bc.ca
- Phone: 6048752359
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Post-marketing surveillance of a femoral stem prosthesis for hip replacement
This study is tracking how well a specific hip replacement device works and its safety in people aged 18 to 75 who are having hip surgery for different joint problems.
-
ROMAX hip resurfacing: expected clinical and radiological outcomes over 10 years
This project will test how well the ROMAX hip resurfacing implant works and how safe it is over 10 years in adults aged 18–65 who receive hip resurfacing for arthritis or congenital hip problems.
-
Comparing observation and bracing for mild hip dysplasia in infants
This study tests if watching and monitoring infants with mild hip dysplasia is just as good as using braces to help them, to see if we can avoid unnecessary treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.